AstraZeneca PLC

Change company Symbol lookup

Select an option...

AZN AstraZeneca PLC

LBUY Leafbuyer Technologies Inc

CSTR CapStar Financial Holdings Inc

MPSFF RevoluGROUP Canada Inc

TDG TransDigm Group Inc

IX Orix Corp

BAC Bank of America Corp

MER-K Bank of America Corp

TGLDF Trillium Gold Mines Inc

NILSY GMK Noril'skiy Nikel' PAO

Go

AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.

ADR Fees

American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees